Related Experiment Videos

A teratological evaluation of anticonvulsant drugs

Acta Paediatrica Academiae Scientiarum Hungaricae
|January 1, 1977
PubMed

Insights

This study investigated anticonvulsant use during pregnancy and congenital malformations in Hungary. Diphenylhydantoin was confirmed as teratogenic, but diazepam and phenobarbital were not linked to birth defects.

Area of Science:

  • Medical Science
  • Pharmacology
  • Teratology

Background:

  • Anticonvulsant medications are frequently prescribed during pregnancy.
  • Potential teratogenic effects of anticonvulsants require thorough investigation.
  • Understanding drug safety during gestation is crucial for maternal and infant health.

Purpose of the Study:

  • To evaluate the teratogenic potential of specific anticonvulsants used during pregnancy.
  • To analyze data from the Hungarian Congenital Malformation Register regarding anticonvulsant exposure and birth defects.
  • To assess the association between diphenylhydantoin, diazepam, and phenobarbital with specific congenital malformations.

Main Methods:

  • Retrospective analysis of data from the Hungarian Congenital Malformation Register.
  • Inclusion of infants with cleft lip (with or without cleft palate), posterior cleft palate, anencephaly, and spina bifida.
  • Determination of anticonvulsant use (diphenylhydantoin, diazepam, phenobarbital) during pregnancy in affected infants and controls.

Main Results:

  • The teratogenic effect of diphenylhydantoin was confirmed in the study population.
  • No significant association was found between the use of diazepam during pregnancy and the occurrence of investigated congenital malformations.
  • Phenobarbital use during pregnancy was not supported as a teratogenic factor for the studied birth defects.

Conclusions:

  • Diphenylhydantoin is a confirmed teratogen, necessitating careful consideration during pregnancy.
  • Current data do not support a teratogenic role for diazepam and phenobarbital in the development of cleft lip/palate, anencephaly, or spina bifida.
  • Further research may be warranted to fully elucidate the safety profiles of various anticonvulsants in pregnancy.

Related Concept Videos